Published on in Vol 3, No 1 (2017): Jan-Mar
1 GlaxoSmithKline, Research Triangle Park, NC, United States
2 Gyra MediPharm Consulting, Research Triangle Park, NC, United States
3 Epidemico, Inc, Boston, MA, United States
4 GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom
5 National Drug and Alcohol Research Centre, UNSW Australia, Randwick, Australia
6 Bluelight.org, Dover, DE, United States
7 Kadiant Analytics, Boston, MA, United States
*these authors contributed equally